Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocklatan vs Latanoprost Post-DSLT in Glaucoma
NCT07465913Phase 4Recruiting
- Sponsor
- Eye Centers of Southeast Texas
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of netarsudil in Glaucoma, sponsored by Eye Centers of Southeast Texas. Started May 2026; status: recruiting.
02
Drugs
netarsudil
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT07465913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07465913.